Acurx Pharmaceuticals Inc. (ACXP): Bathi resik saben saham (EPS TTM)

The development of antibiotics for intensive care units provides Acurx Pharmaceuticals (ACXP) with stable hospital demand, establishing a strong brand reputation among physicians. The TTM net income per share confirms this trend, with the current value standing at -2.33. The picture is completed by prolonged clinical trials and the fight against resistance, which require constant investment in R&D to protect patents.

ACXP Bathi saben saham sajroning taun lumaku Acurx Pharmaceuticals (04.07.2022 - 14.11.2026)

Acurx - rincian analitis lan metrik utama (ACXP)

- rega saham lan target rega konsensus:

Rega saham Acurx Pharmaceuticals Inc.|ACXP - Target median analis

- data kapitalisasi bursa:

Kapitalisasi pasar Acurx Pharmaceuticals, Inc.|ACXP - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- rincian valuasi buku bisnis:

Aset Bersih saben Siji Saham Acurx Pharmaceuticals|ACXP - Nilai Akuntansi Perusahaan|Rasio Nilai Pasar marang Nilai Buku acurxpharma.com|ACXP - Aset Perusahaan

- data utang lan likuiditas:

Total Utang marang Modal Acurx Pharmaceuticals|ACXP - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Acurx|ACXP - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Acurx Pharmaceuticals|ACXP - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Acurx Pharmaceuticals|Rasio cepet acurxpharma.com

- data bathi lan kelipatan valuasi:

ACXP - Penghasilan resik|Bathi mangsa ngarep Acurx Pharmaceuticals|ACXP - Pangali P/E|Rega marang bathi mangsa ngarep Acurx Pharmaceuticals, Inc.|ACXP - Koefisien bali modal nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Acurx Pharmaceuticals|ACXP - Bathi operasional sadurunge amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Acurx Pharmaceuticals|ACXP - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan acurxpharma.com|ACXP - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Acurx Pharmaceuticals

- rincian pendapatan lan dodolan emiten:

ACXP - Pendapatan dodolan perusahaan|Prakiraan volume dodolan Acurx Pharmaceuticals|ACXP - Multiplikator P/S|Rasio rega marang prakiraan pendapatan Acurx Pharmaceuticals, Inc.

Analisis dhasar perusahaan:ACXP - Acurx Pharmaceuticals

Produk sing diprodhuksi Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals focuses on developing innovative antibiotics to combat resistant pathogens. This indicator calculates the aggregate net income over a rolling year divided by the total number of shares. This metric allows for an assessment of the real return on each share of capital, eliminating distortions from one-time payments. Investors use this calculation to determine the fair value of the asset and analyze the risks of overpayment. The trend in fundamental earnings per share TTM reflects the financial efficiency of developing targeted drugs.

Pesaing Acurx Pharmaceuticals

Armata Pharmaceuticals Inc - Bathi resik saben saham (EPS TTM)